Replies to post #45 on Equity Field Notes from temporal sources

[DanWebzster]

RGNX update

licenses out adeno-associated virus technology to other gene-editing companies.

has 20+ partnered programs

When NVS acquired AVXS , that triggered a clause in the AVXS-RGNX partnership contract stepped cup cash milestones to RGNX.

As a result cash is now more than $420mn.